Merit Medical up 6% to 52-week high on analyst upgrade

Tweet   

Merit Medical Systems Inc. (Nasdaq:MMSI) is up 6% today after analysts at C.L. King upgraded the company to “accumulate” from “neutral.” The firm set a price target of $21 for the South Jordan, Utah-based medical device manufacturer. In today’s trading, shares are at $18.98 at 2:10 p.m. ET, up $1.15 from Monday’s close; trading volume is more than triple the average number of shares. The stock soared to a 52-week high of $19.48 early in the trading day. Merit Medical System shares are up more than 36% since January.

For detailed price information and recent news stories about Merit Medical Systems Inc., click MMSI.